openPR Logo
Press release

Infectious Diseases Prevention Management to Drive the Rapid Medical Diagnostic Kits Market

12-21-2016 02:49 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Infectious Diseases Prevention Management to Drive the Rapid

Rapid medical diagnostics are tools for detection of various infectious diseases caused by virus and bacteria. Since the last decade remarkable prevalence of infectious diseases has been observed worldwide and its morbidity rate is rapidly growing. Increased detection of new pathogens-causing infections and increasing rate of weak immune system resulting from aging of population worldwide are some of the major factors leading to increase in the infectious diseases due to which the rapid medical diagnostic kits market is showing massive growth globally.

Some other factors contributing to the growth of the rapid medical diagnostic kits market include cheaper cost of the rapid medical diagnostic kits, and increasing awareness about the available technologies for diagnosis of the infectious diseases caused by virus and bacteria.

Request Sample of Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1301

Rapid medical diagnostic kits are used for detecting or diagnosing a wide range of infections, conditions, and diseases that the person might be suffering from. These kits offer an accurate diagnosis for diseases such as malaria and conditions such as diabetes and pregnancy. These kits are also known as quick diagnostic tests are they deliver results in a matter of minutes or hours and do not require automated diagnostic equipment in any form.

According to the comprehensive document, the global rapid medical diagnostic kits market was valued at US$17.65 bn in 2012. However, by the end of the forecast period, this market is expected to reach US$25.76 bn expanding at a CAGR of 5.5% between 2013 and 2019.

The global rapid medical diagnostic kits market is moving ahead at a moderate pace and is expected to witness a continuous demand for the products for management various diseases. The growth of the global rapid medical diagnostic kits market has stirred a meaningful revolution in the healthcare sector by offering simple ways to seek immediate answers by detecting ailments. The high incidence of sexually transmitted diseases, infectious diseases, diabetes, gastrointestinal diseases, and hepatitis are some of the key factors driving the overall rapid medical diagnostic kits market.

The global rapid medical diagnostic kits market is segmented on the basis of application, technology, and geography. The application segment is segmented into clinical testing, home-use, and veterinary. The technologies used in this market are flow through, lateral flow, solid phase, and agglutination assays. Geographically, this market is segmented into Europe, North America, Asia Pacific, and Rest of the World.

Presently, North America holds a significant share in the overall market, with Europe following its lead. Analysts predict that North America is expected to retain its spot due to growing consumer awareness. In the same forecast period, the Asia Pacific rapid medical diagnostic kits market is expected to witness a remarkable boost due to the growing prevalence of diseases, improving disposable incomes, and rising awareness amongst consumers about these kits. Additionally, the growing cases of infectious diseases in Africa are expected to support the growth of this market in the region.

Browse Research Report: http://www.transparencymarketresearch.com/rapid-medical-diagnostic-kits.html

Some of the leading players in the global medical diagnostic kits market are Abbott Laboratories, Abaxis, Inc., Alere, Inc., BioRad Laboratories, Becton Dickinson & Company, MegaCor Diagnostik GmbH, Danaher Corporation, MegaCor, Trinity Biotech Plc, Zoetis, Inc., and F. Hoffmann La Roche.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Infectious Diseases Prevention Management to Drive the Rapid Medical Diagnostic Kits Market here

News-ID: 400003 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Rapid

UYEE Rapid Tooling Announces Expert CNC Machining and Rapid Prototyping Services
UYEE Rapid Tooling Co., Ltd, a trusted provider since 2005, announces its advanced capabilities in high-speed CNC machining, rapid prototyping, and low volume manufacturing solutions. UYEE Rapid Tooling Co., Ltd, a dedicated leader in manufacturing services since 2005, today highlighted its comprehensive suite of services designed to meet the demanding needs of modern product development and production. With a strong commitment to customer success, UYEE specializes in delivering high-speed CNC machining,
Rapid Infuser Market - Swift Restoration, Enhanced Recovery: Rapid Infuser Optim …
Newark, New Castle, USA: The "Rapid Infuser Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Rapid Infuser Market: https://www.growthplusreports.com/report/rapid-infuser-market/8896 This latest report researches the industry structure, sales, revenue,
Rapid Infuser Market - From Emergency to Efficiency: Advancing Patient Outcomes …
Newark, New Castle, USA - new report, titled Rapid Infuser Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Rapid Infuser market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Rapid Infuser market. The report offers an overview of the market, which
Rapid Pregnancy Tests Market: Size & Trends Shows a Rapid Growth by 2027
The pregnancy test kit confirms pregnancy by detecting the level of human chorionic gonadotropin (HCG) in the urine. The growing demand for an easy and convenient way to get faster results, and the easy availability of pregnancy kits through various distribution channels, including pharmacies/pharmacies, online stores, etc., is increasing the demand for pregnancy test kits. (Get 15% Discount on Buying this Report) A full report of Global Rapid Pregnancy Tests Market is
Rapid Machining Launches New Service
Rapid Machining, one of the largest prototype machining manufacturers in the United States, is excited to announce a new standard 5 day lead time service for lathe parts. Responding to customer demand, Rapid Machining purchased new equipment and reconfigured the manufacturing floor to make this lead-time reduction possible from a standard 7 day lead time. The new service is currently available for lathe parts with a variety of materials and
RAPID: Lockheed Martin Approved
Nashua, NH – April 4, 2016 – RAPID was announced as an approved vendor for Lockheed Martin as of April 2016. RAPID has been working with Lockheed Martin divisions for a number of years, but the addition to the Approved Vendor list will strengthen and build upon the existing relationship. Lockheed Martin is an aerospace, defense, security, and advanced technology company that employs over 116,000 professionals worldwide. Lockheed Martin has